Sparsha Pharma USA

Founded in 2012, Sparsha Pharma USA (Sparsha USA) is a pharmaceutical manufacturing company dedicated to medical film products such as transdermal/topical patches and oral films. Sparsha USA has established its own patch production line with unique manufacturing equipment, and also has QC analytical labs capable of analyzing raw materials to finished products. Sparsha USA has the capability of pharmaceutical production, R&D for future pipeline products, CMO/CDMO, and analytical service. 

Products and Services

In 2020, Sparsha USA developed and launched a lidocaine 4% over-the-counter patch (their own brand, Niravi). In addition, Sparsha USA currently produces private-label lidocaine 4% patches for several customers including major pharmacies.

Sparsha USA specializes in transdermal/topical patch and oral film products. Sparsha USA holds required licenses such as a State of California Dept. of Public Health Food and Drug Branch - Drug Manufacturing license and Drug Enforcement Administration (DEA) licenses; and are Good Manufacturing Practice (GMP) certified by NSF, 2021.

Manufacturing Processes

Common manufacturing processes for Sparsha USA's pharmaceutical film products are mixing, coating, slitting, cutting, and packaging. Sparsha USA also customizes settings as per the product requirement.